Nu-Med Plus, Inc. (NUMD) stock
NUMDOTCGold and Silver OresFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 3/30
$0.01−0.00 (-8.16%)
Close on Oct 19, 2026Market cap $601.55KP/E –Yield –
Nu-Med Plus operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Nu-Med Plus's operating income for the twelve months ending Jun 30, 2026 was -$55.54K. For fiscal 2025 it was -$48.96K. The highest annual figure on record is -$48.96K in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$48.96K | – |
| FY2024 | Dec 31, 2024 | -$63.33K | – |
| FY2023 | Dec 31, 2023 | -$120.53K | – |
| FY2022 | Dec 31, 2022 | -$182.17K | – |
| FY2021 | Dec 31, 2021 | -$839.45K | – |
| FY2020 | Dec 31, 2020 | -$1.99M | – |
| FY2019 | Dec 31, 2019 | -$1.02M | – |
| FY2018 | Dec 31, 2018 | -$1.17M | – |
| FY2017 | Dec 31, 2017 | -$466.52K | – |
| FY2016 | Dec 31, 2016 | -$1.22M | – |
| FY2015 | Dec 31, 2015 | -$946.48K | – |
| FY2014 | Dec 31, 2014 | -$1.15M | – |
| FY2013 | Dec 31, 2013 | -$233.64K | – |
| FY2012 | Dec 31, 2012 | -$258.23K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$22.56K | – |
| Q1 FY2026 | Mar 31, 2026 | -$13.15K | – |
| Q4 FY2025 | Dec 31, 2025 | -$9.76K | – |
| Q3 FY2025 | Sep 30, 2025 | -$10.08K | – |
| Q2 FY2025 | Jun 30, 2025 | -$10.42K | – |
| Q1 FY2025 | Mar 31, 2025 | -$18.70K | – |
| Q4 FY2024 | Dec 31, 2024 | -$9.29K | – |
| Q3 FY2024 | Sep 30, 2024 | -$17.42K | – |
| Q2 FY2024 | Jun 30, 2024 | -$16.04K | – |
| Q1 FY2024 | Mar 31, 2024 | -$20.58K | – |
| Q4 FY2023 | Dec 31, 2023 | -$55.34K | – |
| Q3 FY2023 | Sep 30, 2023 | -$15.15K | – |
| Q2 FY2023 | Jun 30, 2023 | -$23.07K | – |
| Q1 FY2023 | Mar 31, 2023 | -$26.97K | – |
| Q4 FY2022 | Dec 31, 2022 | -$6.39K | – |
| Q3 FY2022 | Sep 30, 2022 | -$58.05K | – |
| Q2 FY2022 | Jun 30, 2022 | -$58.07K | – |
| Q1 FY2022 | Mar 31, 2022 | -$59.65K | – |
| Q4 FY2021 | Dec 31, 2021 | -$112.34K | – |
| Q3 FY2021 | Sep 30, 2021 | -$118.37K | – |
| Q2 FY2021 | Jun 30, 2021 | -$251.99K | – |
| Q1 FY2021 | Mar 31, 2021 | -$356.75K | – |
| Q4 FY2020 | Dec 31, 2020 | -$491.16K | – |
| Q3 FY2020 | Sep 30, 2020 | -$449.76K | – |
| Q2 FY2020 | Jun 30, 2020 | -$904.45K | – |
| Q1 FY2020 | Mar 31, 2020 | -$149.31K | – |
| Q4 FY2019 | Dec 31, 2019 | -$205.70K | – |
| Q3 FY2019 | Sep 30, 2019 | -$146.21K | – |
| Q2 FY2019 | Jun 30, 2019 | -$243.79K | – |
| Q1 FY2019 | Mar 31, 2019 | -$423.73K | – |
| Q4 FY2018 | Dec 31, 2018 | -$335.97K | – |
| Q3 FY2018 | Sep 30, 2018 | -$522.07K | – |
| Q2 FY2018 | Jun 30, 2018 | -$168.71K | – |
| Q1 FY2018 | Mar 31, 2018 | -$142.56K | – |
| Q2 FY2017 | Jun 30, 2017 | -$111.30K | – |
| Q1 FY2017 | Mar 31, 2017 | -$69.73K | – |
See a number that looks wrong?